Critical flicker frequency for quantification of low‐grade hepatic encephalopathy
暂无分享,去创建一个
Lars Timmermann | Alfons Schnitzler | Dieter Häussinger | Gerald Kircheis | A. Schnitzler | L. Timmermann | D. Häussinger | G. Kircheis | M. Wettstein | Matthias Wettstein
[1] H. Misiak,et al. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects—A review , 1976, Psychopharmacology.
[2] A. Reichenbach,et al. Hepatic retinopathy: morphological features of retinal glial (Müller) cells accompanying hepatic failure , 2004, Acta Neuropathologica.
[3] K Weissenborn,et al. Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.
[4] G. Marchesini,et al. Factors associated with poor health-related quality of life of patients with cirrhosis. , 2001, Gastroenterology.
[5] R. Silberstein,et al. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor , 2000, Behavioural pharmacology.
[6] R Fischer,et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? , 2000, Journal of hepatology.
[7] W. Hop,et al. Screening of subclinical hepatic encephalopathy. , 2000, Journal of hepatology.
[8] R. Butterworth. Complications of cirrhosis III. Hepatic encephalopathy. , 2000, Journal of hepatology.
[9] W. Cevallos,et al. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. , 2001, British journal of clinical pharmacology.
[10] A. Blei,et al. Pathophysiology of cerebral edema in fulminant hepatic failure. , 1999, Journal of hepatology.
[11] I. Hindmarch,et al. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. , 1999, British journal of clinical pharmacology.
[12] P. Angeli,et al. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests , 1999, Hepatology.
[13] W. Hop,et al. Subclinical hepatic encephalopathy impairs daily functioning , 1998, Hepatology.
[14] H. Scheinin,et al. The Effects of Branched Chain Amino Acid Infusion on Pain Perception and Plasma Concentrations of Monoamines , 1998, Pharmacology Biochemistry and Behavior.
[15] I. Anderson,et al. Information processing in anxiety: a pilot study of the effect of manipulating 5-HT function , 1998, Journal of psychopharmacology.
[16] E. Zrenner,et al. Hepatic Retinopathia. Changes in Retinal Function , 1997, Vision Research.
[17] S W Schalm,et al. Subclinical Hepatic Encephalopathy , 1996, Seminars in liver disease.
[18] G. Pomier‐Layrargues. TIPS and hepatic encephalopathy. , 1996, Seminars in liver disease.
[19] A. Herneth,et al. Newer Approaches to Therapy of Hepatic Encephalopathy , 1996, Seminars in liver disease.
[20] S. Bluml,et al. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? , 1996, Digestive diseases.
[21] J. Schölmerich,et al. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. , 1995, Journal of hepatology.
[22] A. Rademaker,et al. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. , 1994, Journal of hepatology.
[23] H. Schomerus,et al. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. , 1993, Zeitschrift fur Gastroenterologie.
[24] K. D. Kubinger. Testtheoretische Probleme der Computerdiagnostik , 1993 .
[25] Suzanne Corkin,et al. Visual dysfunction in Alzheimer's disease: Relation to normal aging , 1991, Annals of neurology.
[26] R. Butterworth,et al. Subclinical Hepatic Encephalopathy in Cirrhotic Patients: Prevalence and Relationship to Liver Function , 1991 .
[27] M. Mehndiratta,et al. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. , 1990, The American journal of gastroenterology.
[28] Y. Liaw,et al. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. , 1990, Hepato-gastroenterology.
[29] R. Hawkins,et al. Cerebral function in hepatic encephalopathy. , 1990, Advances in experimental medicine and biology.
[30] P. Angeli,et al. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. , 1989, The American journal of gastroenterology.
[31] N. Gitlin,et al. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. , 1986, Journal of hepatology.
[32] T. Salmi. Critical flicker frequencies in MS patients with normal or abnormal pattern VEP , 1985, Acta neurologica Scandinavica.
[33] T E Starzl,et al. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. , 1984, Gastroenterology.
[34] D. Freides,et al. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. , 1978, Gastroenterology.
[35] E. Lewis,et al. The effect of alcohol on sensory phenomena and cognitive and motor tasks. , 1969, Quarterly journal of studies on alcohol.
[36] A. Mahneke. FLICKER‐FUSION THRESHOLDS , 1957, Acta ophthalmologica.
[37] A. Mahneke. FLICKER FUSION THRESHOLDS , 1956 .
[38] A. Ivy,et al. Effect of analeptic drugs on the somnifacient effect of seconal and antihistaminics as measured by the flicker fusion threshold. , 1952, Journal of applied physiology.